Interés Humano

EE. UU. autoriza dosis de refuerzo de Pfizer para adolescentes

Autoridades sanitarias también redujeron de seis a cinco meses el tiempo antes de la inyección de la tercera dosis para todas las edades

(FILES) In this file photo taken on May 13, 2021 Oliver Barr, 13, receives his Covid-19 vaccine administered by medical assistant Karina Cisneros from St. John's Well Child & Family Center at Abraham Lincoln High School in Los Angeles, California. - US health authorities on January 3, 2022 approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages. (Photo by Frederic J. BROWN / AFP)
(FILES) In this file photo taken on May 13, 2021 Oliver Barr, 13, receives his Covid-19 vaccine administered by medical assistant Karina Cisneros from St. John's Well Child & Family Center at Abraham Lincoln High School in Los Angeles, California. - US health authorities on January 3, 2022 approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages. (Photo by Frederic J. BROWN / AFP) FREDERIC J. BROWN

Washington. Las autoridades sanitarias estadounidenses autorizaron este lunes el refuerzo de la vacuna de Pfizer para adolescentes de 12 a 15 años y redujeron de seis a cinco meses el tiempo antes de la inyección de esta tercera dosis para todas las edades.

La decisión se toma en medio de un brote de covid-19 debido a la variante ómicron y cuando los escolares se disponen a volver a clases después de las vacaciones de fin de año.

‌
‌

‌

‌
‌

‌

‌